Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Superinvestors holding VERV, Q2 2025
No superinvestor reported holding VERV in Q2 2025.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of VERV each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q2 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−51.4%)
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−14.0%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+35.1%)
Q3 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+1.0%)
Q2 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+14.9%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+2.7%)
Q4 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+28.6%)
Q3 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+66.8%)
Q2 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+20.6%)
Q1 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+20.5%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+10.4%)
Q3 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+131.2%)
Q2 2021
1 superinvestor holding at quarter end
- New
- ARK Invest